18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma.
Kong Z, Lin Y, Jiang C, Li L, Liu Z, Wang Y, Dai C, Liu D, Qin X, Wang Y, Liu Z, Cheng X, Tian J, Ma W.
Kong Z, et al. Among authors: lin y.
Cancer Imaging. 2019 Aug 19;19(1):58. doi: 10.1186/s40644-019-0246-0.
Cancer Imaging. 2019.
PMID: 31426864
Free PMC article.